Vaccines 2021

A historic milestone in the global effort to combat malaria: the World Health Organization (WHO) has approved the first vaccine to address the disease. The vaccine, RTS,S , also known by its brand name Mosquirix, was developed by the British pharmaceutical giant GSK. To date, it has been administered to more than 800,000 children in Ghana, Kenya, and Malawi as part of a pilot immunization program that commenced in 2019. The vaccine's efficacy is estimated at approximately 39% in preventing infection and 29% in preventing severe malaria cases resulting in hospitalization.